SARS-CoV-2 (COVID-19) IgA Ab [Titer] in Serum or Plasma by Immunofluorescence

SARS-CoV-2 IgA Titr SerPl IF

Definition

Quantitative titer results for SARS Coronavirus 2 (SARS-CoV-2) virus IgA antibodies in serum or plasma by an immunofluorescent method, such as Indirect fluorescent antibody testing (IFAT) or Micro Immunofluoresence (MIF). This test may be used in conjunction with SARS-CoV-2 IgM and IgG to aid in the diagnosis of COVID-19 and in the identification of individuals infected with SARS-CoV-2.

2019 Novel Coronavirus; 2019-nCoV; ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Corona virus; COVID19; COVID-19; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; II; Immune fluorescence; Immune globulin A; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin A; Infectious Disease; InfectiousDisease; Microbiology; PH; Pl; Plasma; Plsm; Point in time; Public Health; PublicHealth; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SerP; SerPl; SerPlas; Serum; Serum or plasma; Severe Acute Respiratory Syndrome; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Viral Pneumonias; Wuhan coronavirus

21 further terms